Moderna continues volatile trading with 9% gain (MRNA:NASDAQ)
· seekingalpha.com
Moderna (MRNA) jumps 9% as Phase 3 melanoma data fuels momentum.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...